# Myota

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myota-2

- Industry: Food
- Headquarters: Berlin, Germany
- Website: www.myotahealth.com/
- Total disclosed funding: $4.5M
- Latest round: Series A (Jun 11, 2026)
- Investors on record: 3

## About

Myota GmbH, based in Berlin, Germany, specializes in advanced prebiotic solutions aimed at enhancing gut health and overall well-being through unique fiber-based products.Myota GmbH is focused on developing innovative gut health solutions. The company raised USD 4.5 mn in Series A funding on June 11, 2026, led by PeakBridge, with participation from Bowbridge MCO Ltd and Denava Ag. The total amount raised by the company stands at USD 4.5 mn, with a current valuation of USD 17.48 mn. Myota GmbH was co-founded by visionary entrepreneurs dedicated to advancing digestive health, although further details on additional ventures are not available.Myota Health specializes in gut health solutions, primarily offering a range of fiber-based products designed to support digestive health, cognitive function, and overall well-being. Their flagship offerings include a three-month gut reset program that incorporates their unique blends of prebiotic fiber, promoting the growth of beneficial gut bacteria while reducing inflammation and regulating blood sugar levels. The products are particularly suited for individuals with sensitive digestive systems and those seeking to restore balance within their gut microbiome. Myota's customer base primarily consists of health-conscious consumers, including those with dietary restrictions and individuals looking to improve their metabolic and heart health. The company markets its products in various regions, including the United Kingdom and other European markets, ensuring accessibility for a wide audience interested in enhancing gut health through scientifically backed dietary supplements.Myota Health generates revenue through direct-to-consumer sales of its health products, which include subscription plans and one-time purchases. Customers can sign up for a monthly subscription service that provides a continuous supply of their gut health products, including the Metabolic Health and Gut Health fiber blends, priced at approximately GBP 32.50 per month, with on-the-go bars available at GBP 2 each. This structured approach allows the company to create a predictable revenue stream while catering to individual consumers and those seeking convenient, portable health solutions. Myota fosters customer loyalty through promotional offers, such as discounts on initial purchases and free starter kits, incentivizing users to engage with their product line.Myota GmbH plans to utilize its recent Series A funding of USD 4.5 mn to enhance product development and expand into new markets. The company is working on launching additional gut health products designed to cater to diverse consumer needs, with expected releases in the upcoming year. Geographically, Myota aims to penetrate additional European markets by mid-2027, focusing on regions where gut health awareness is growing. The funding will support these initiatives, ensuring Myota remains at the forefront of gut health innovation.

## Funding rounds

- Series A, Jun 11, 2026, $4.5M — PeakBridge, Denava Ag, Bowbridge MCO Ltd

## Investors

- PeakBridge (https://capitalatlas.ai/funds/peakbridge) — Series A
- Denava Ag — Series A
- Bowbridge MCO Ltd — Series A